In summary, our study revealed that DHA exerts a therapeutic effect on obesity in an HFD-induced obese mice by inhibiting adipocyte differentiation, and that its mechanism of action may lie in its inhibitory effect on the ROS-producing enzyme NOX4 and abnormal cell-metabolism pathways. Here, NOX4 is linked to obesity disorder.